The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance
Aidan Toner(Ollscoil na Gaillimhe – University of Galway), Sharon A. Glynn(Dublin City University)
Cited by 12
Related Papers
The Role of Nitric Oxide in Cancer: Master Regulator or NOt?
|International Journal of Molecular Sciences|2020|171
Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways
|Oncotarget|2017|89
COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer
|BMC Cancer|2010|79